Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SPAG9 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TRIM2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
UFL1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
DHX29 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TET3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CSAD - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
EPB41L3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
DMTF1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
DOCK9 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TMEM50A - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SLC30A4 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PCDH9 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RDH11 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
DCUN1D1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
DMXL1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ANAPC5 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CDK17 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PIKFYVE - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PCF11 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PTBP2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on